Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

Lilly expects to submit five drugs for US approval in 2013

Hopes FDA submissions will help offset patent losses for Zyprexa and Cymbalta

Novartis building

Novartis hit by kickback lawsuits in US

Company accused of paying millions of dollars to doctors in exchange for prescribing drugs

Online Parkinson’s community launched

Britannia Pharmaceuticals' initiative focuses on mid- to late-stages of the disease

- PMLiVE

Two new cancer drugs recommended in Europe

CHMP backing for Roche's Erivedge and Astellas' Xtandi

- PMLiVE

Endocyte brings in senior figures from BMS and Amgen

Appoints Torsten Hoof and Ulf Staginnus as company prepares to launch cancer drugs

- PMLiVE

Beyond advertising in healthcare

The world of healthcare advertising is evolving. Intriguingly, many agencies are asking the same question: what is advertising these days?

- PMLiVE

Getting UK market access right

The importance of a local value story in UK Market Access - practical insights on how to ensure product adoption in the UK

- PMLiVE

EMA refuses to back Pfizer’s Xeljanz in rheumatoid arthritis

Surprise after approvals in US and Japan

ABPI London offices

ABPI: Pharma must sell outcomes, not products

Annual conference told industry must re-establish its social contract with the NHS

Novartis building

NICE turns down Novartis’ blood cancer drug Jakavi

Uncertainties remain about drug’s cost-effectiveness, according to final draft guidance

Cromos hires Andrey Bazovoy from Quintiles

Joins CRO as director clinical operations

- PMLiVE

AstraZeneca sales hit by Seroquel generics

End of patent exclusivity for antipsychotic among key factors dragging down revenues

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links